FDA Mulls Killing Safety Study on Diabetes Drug
2010/04/19 06:39:27 @FOXNews.com
U.S. regulators are considering ending a safety study on GlaxoSmithKline's diabetes drug Avandia, the Wall Street Journal reported on Sunday, saying the move could also jeopardize the drug's presence in the U.S. market. [ VIEW FULL COVERAGE @FOXNews.com ]